Recent Highlights
All Stories for Sinopharm
As countries scramble for COVID-19 jabs, Mongolia's vaccine stocks swell
• 4 years agoMongolia, using its status as a small geopolitical player between Russia and China, was able to purchase 5 million doses from both countries
From supply chains to vaccines, China has frequently thrown spanner into works of India's COVID-19 battle
Fp Staff • 4 years agoFrom tactfully disallowing Chinese firms to participate in BMC's global vaccine tender to exorbitant pricing of necessary equipment, India's battle against COVID-19 has often run into rough weather with China
WHO approves China's Sinopharm COVID-19 vaccine for emergency use
• 4 years agoSinopharm is a two jab inactivated vaccine and its easy storage requirements make it highly suitable for low-resource settings, the WHO said in a statement
Imran Khan testing COVID-19 positive days after Sinopharm dose raises questions about efficacy of China's vaccine
Fp Staff • 4 years agoPakistan has launched its vaccination drive for the general public on 10 March, starting with elderly people after seeing a poor response from front-line health workers, who expressed concerns about the Chinese vaccine
Pfizer, Moderna, Astrazeneca, Bharat Biotech, other COVID-19 vaccines in use or getting close
• 4 years agoThe shots were all tested differently, and some were allowed to go into use even before they were rigorously tested.
Bahrain approves use of Chinese COVID-19 vaccine; Kuwait gives nod for emergency use of Pfizer vaccine
• 4 years agoBahrain said over 7,700 signed up to take part in a trial of the Sinopharm vaccine in the Kingdom, but offered few details on the results of the study
China prepares for rollout of domestic Covid-19 vaccines in trial, pursues international deals
• 4 years agoOrders for experimental, domestic Covid-19 vaccines are coming in, even though health officials are yet to vouch for them.
Pfizer announces $1.95 billion deal to produce 100 million doses of coronavirus vaccine by year-end
• 5 years agoPfizer said that large-scale safety and efficacy trials were to begin this month, with a regulatory review set for as early as October, although nothing was guaranteed.
CanSino Biologics in talks with Russia, Brazil, Chile, Saudi Arabia to launch Phase III trial of its COVID-19 vaccine
• 5 years agoQiu Dongxu co-founder of CanSino said its new factory under construction in China will allow it to produce 100-200 million vaccine doses per year by early 2021.
COVID-19 vaccine: Potential coronavirus vaccine candidate from China shows promise in animal tests
• 5 years agoMore than 100 potential COVID-19 vaccines are in various stages of development around the world.